Download in PDF formatFormulations
A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio
Read >>
A wide array of more than 850 products to meet most unmet medical needs, catering to a vast and diverse therapeutic portfolio
Read >>More than 38 APIs and intermediates including USFDA – certified products are manufactured at our ISO-9002 & ISO14001 accredited facilities at Ankleshwar, India
Read >>
Innovative products like ‘Polycap’ for cardiovascular disease, Risorine for Tuberculosis and Mycidac –C for lung cancer have been developed inhouse
Read >>Three state of the art manufacturing facilities in the state of Gujarat, Jammu (India) and Ethiopia are approved by all prominent international regulatory bodies, including USFDA
Read >>
Disclaimer
Public at large are hereby cautioned about fraudulent activities and false commitments inviting general public at large to deposit/invest funds with trust associated investment activities carried out with malicious intent in the name of CADILA by using deceptive stationary like letterhead, round stamp and thereby wrongly misleading the public at large.
Such activities are carried out by some group of fraudsters with an intention to cheat under wrongful commitment and allurement. Therefore, CADILA advises the general public to not take the bait and avoid giving their confidential details or money to such false/fabricated commitments.
CADILA is not involved in such fraudulent activities and hence is not liable, responsible or answerable in case of any financial deception. CADILA shall not entertain, answer or attend any such fraudulent claims thereunder if any.
Cadila Pharmaceuticals Limited, established in 1951 is one of the largest privately held pharmaceutical companies in India. An innovation and research focused company, we have been developing, manufacturing, selling and distributing pharmaceutical products across more than 45 therapeutic areas
Read >>
Mr. Indravadan A. Modi, Founder Chairman of Cadila Pharmaceuticals is called the Medicine Man of India. He was also the Champion of Indian Patents Act, 1970. He believed in making medicine affordable to the last man in the society.
Read >>
Cadila Pharmaceuticals with a significant presence in over 90 countries has a multicultural, multilingual and multinational workforce of more than 7000 employees including over two hundred people outside India in Africa, CIS, Japan and USA
Read >>Drug counterfeiting is a serious offence worldwide and claims many lives every year, while jeopardizing the lives of others. Today, counterfeiters are increasingly employing deceitful tactics to lure people with cheaper, but fatal drugs. Typically, counterfeiting today employs many mechanisms viz. absence of active ingredient, low levels of active ingredient, replacing safe drugs with poor-quality drugs and wrong packaging.
As a responsible corporate house, Cadila Pharmaceuticals Limited has started a drive against infringement or counterfeiting of its products. In this journey we urge you all to join and support us by reporting any type of counterfeiting of any of our products. You can mail us at website@cadilapharma.co.in or call us on +91 - 2718 - 225001 and provide the details of the product mentioned below.